The Association Between Medroxyprogesterone Acetate Exposure and Cerebral Meningioma Among a Medicaid Population [PDF]
Background/Objectives: Medroxyprogesterone acetate (MPA) is a synthetic contraceptive that can be used orally or as a once-every-three-month injection (i.e., depot MPA [dMPA]).
Lindy M. Reynolds +2 more
doaj +4 more sources
Medroxyprogesterone acetate and meningioma: a global issue [PDF]
Noémie Roland +2 more
doaj +4 more sources
Depot medroxyprogesterone acetate (DMPA)-associated early-onset osteoporotic fracture [PDF]
Depot medroxyprogesterone acetate (DMPA) is a highly effective injectable contraceptive, but is associated with reduced bone mineral density (BMD) and increased fracture risk in some studies because it inhibits the hypothalamic–pituitary–ovarian axis ...
Yotsapon Thewjitcharoen +3 more
doaj +2 more sources
Live Birth Outcomes After Extended or Repeated High-Dose Medroxyprogesterone Acetate Therapy for Fertility-Sparing Management of Endometrial Neoplasia: A Single-Center Retrospective Case Series. [PDF]
ABSTRACT Aim To clarify live birth outcomes among women receiving extended or repeated high‐dose medroxyprogesterone acetate (MPA) therapy for fertility‐sparing management of atypical endometrial hyperplasia or endometrioid carcinoma grade 1. Methods We conducted a single‐center retrospective case series of 53 patients undergoing MPA therapy between ...
Yamamura A +9 more
europepmc +2 more sources
Progestin-primed ovarian stimulation with letrozole using different doses of medroxyprogesterone acetate per day: a retrospective cohort study [PDF]
BackgroundIn the progestin-primed ovarian stimulation protocol, the oral administration of medroxyprogesterone acetate has been observed to effectively inhibit the LH surge during ovarian stimulation in patients experiencing infertility.
Hai-long Li +12 more
doaj +2 more sources
Thyroid function patterns in Ghanaian women using depo-medroxyprogesterone acetate
Background: The main hormonal contraceptives of choice for most women in Ghana are progestin-only injectables, norethisterone enanthate and depot-medroxyprogesterone acetate (DMPA).
John Cletus Osei +7 more
doaj +2 more sources
A case report and literature review: A 19‐year‐old with endometrial carcinoma treated with medroxyprogesterone acetate. Importance of the medical interview and endometrial examination [PDF]
Key Clinical Message A 19‐year‐old woman had stage IA endometrial carcinoma treated with medroxyprogesterone acetate and experienced a recurrence. This patient's experience illustrates the importance of a thorough history and endometrial assessment in ...
Shinichiro Katsuma +4 more
doaj +2 more sources
Contraception in adolescents with mental disorders: adherence and satisfaction in the use of depot medroxyprogesterone acetate [PDF]
Objective: To evaluate the continuation rate, satisfaction, and reasons for discontinuation of depot medroxyprogesterone acetate (DMPA) in adolescents treated in a mental health service.
Giani Silvana Schwengber Cezimbra +2 more
doaj +2 more sources
The value of diffusion-weighted imaging and semi-quantitative dynamic contrast-enhanced MRI in predicting the efficacy of medroxyprogesterone acetate treatment for atypical endometrial hyperplasia and endometrial carcinoma [PDF]
Background It will be important to noninvasively evaluate the efficacy of treatment for patients with atypical endometrial hyperplasia (AEH) and endometrial carcinoma (EC) who wish to have children. The study aimed to explore the feasibility of diffusion-
Mingming Liu +5 more
doaj +2 more sources
Efficacy and safety of medroxyprogesterone acetate on noninvasive ventilation -treated exacerbated COPD patients: a double-blind randomized clinical trial [PDF]
Background In acute exacerbation periods of chronic obstructive pulmonary disease (COPD), patients may experience hypoxemia or hypercapnia.
Mohsen Gholinataj Jelodar +4 more
doaj +2 more sources

